February 12, 2020 / 2:20 PM / 12 days ago

BRIEF-Cytodyn Signs Letter Of Intent For The Joint Development And Licensing Of Leronlimab In China With Longen China Group

Feb 12 (Reuters) - Cytodyn Inc:

* CYTODYN SIGNS LETTER OF INTENT FOR THE JOINT DEVELOPMENT AND LICENSING OF LERONLIMAB IN CHINA WITH LONGEN CHINA GROUP

* CYTODYN INC - CO, LONGEN WILL BEGIN EXPLORING OPPORTUNITIES FOR LERONLIMAB FOR TREATMENT OF 2019 NOVEL CORONAVIRUS AND CANCER Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below